Sodium (1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl){[4-(2-hydroxy-2-propanyl)-2-furyl]sulfonyl}azanide

2-Furansulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-, sodium salt (1:1)

256373-96-3

Sodium (1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl){[4-(2-hydroxy-2-propanyl)-2-furyl]sulfonyl}azanide

sodium [(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl]({[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonyl})azanide

sodium [(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl][4-(2-hydroxypropan-2-yl)furan-2-ylsulfonyl]azanide

210826-40-7

256373-96-3 (sodium)

CP-456773 sodium

CP-456773 sodium salt

CP-456773 sodium;CRID3 sodium salt;MCC-950 sodium;CP456773 sodium;CRID-3 sodium salt

CP456773 sodium

CRID-3 sodium salt

CRID3 sodium salt

Cytokine release inhibitory drug 3

MCC 950 sodium

MCC-950 sodium

MCC950 (sodium)

MCC950 sodium

MFCD28580120

MFCD30478884

N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide sodium salt

NLRP3_HUMAN

P-456773 Sodium, CRID-3 Sodium Salt

Sodium ((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide